-
-
-
-
-
-
-
Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer
-
-
-
-
-
-
-
Theralase(R) Releases 3Q2025 Financial Statements
-
-
-
-
-
-
-
Theralase(R) Closes Non-Brokered Private Placement
-
-
-
-
-
-
-
Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association
-
-
-
-
-
-
-
Theralase(R) Closes Non-Brokered Private Placement
-
-
-
-
-
-
-
Theralase(R) Launches Three New Clinical Study Sites in USA
-
-
-
-
-
-
-
Theralase(R) Extends Warrants
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

